AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation

AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation

(1) Background: Alpha-fetoprotein (AFP) has been incorporated into the selection criteria of liver transplantation and been used to predict the outcome of hepatocellular carcinoma (HCC) recurrence. Locoregional therapy (LRT) is recommended for bridging or downstaging in HCC patients listed for liver...

Full description

Bibliographic Details
Main Authors: I-Hsuan Chen, Chien-Chin Hsu, Chee-Chien Yong, Yu-Fan Cheng, Chih-Chi Wang, Chih-Che Lin, Chao-Long Chen
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
alpha-fetoprotein
hepatocellular carcinoma
liver transplantation
locoregional therapy
Online Access:https://www.mdpi.com/2072-6694/15/5/1551

Internet

https://www.mdpi.com/2072-6694/15/5/1551

Similar Items